Agili-C

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Commercializzato da:

Cartiheal (2009) Ltd.

Classe:

בית חולים

Prodotto da:

Cartiheal (2009) Ltd.

Gruppo terapeutico:

רופא

Indicazioni terapeutiche:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.

Dettagli prodotto:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.